Atlas Trials

A Study (Study 2) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea

Clinical trial NCT04608500 · COMPLETED

Trial details

NCT number
NCT04608500
Sponsor
Vyne Therapeutics Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Facial Papulopustular Rosacea
Start date
2017-06-01
Primary completion
2018-07-02
Enrollment
771

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.